| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/04/20 | 19 : 04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/14 | 05 : 37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/06 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05 : 57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05 : 55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 05 : 51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/03 | 01 : 32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 07 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 06 : 56 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 06 : 50 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 05 : 36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/02 | 02 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 23 : 52 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 23 : 41 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 22 : 45 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 20 : 31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/03/01 | 20 : 18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 02 : 33 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 01 : 58 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/15 | 01 : 15 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/11 | 06 : 32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 2017/02/11 | 05 : 39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |